Chief Executive Officer
For 12 years Dr. Piervincenzi was a partner and leader in McKinsey & Company's Global Pharmaceutical and Medical Products Practice where, among other responsibilities, he launched McKinsey's global drug safety, medical and regulatory service line. Most recently, as a VP in Development Sciences with Biogen Idec, he launched a new group (Value-Based Medicine) focused on applying tools and technologies of personalized medicine to the multiple sclerosis disease area.
Dr. Piervincenzi earned his M.S. and Ph.D. from Duke University in Biomedical Engineering, with research focused on protein engineering. He is the founder of multiple non-profits in the community service and scientific spaces including serving currently as Board Chair for the Newark Mentoring Movement.
Building on the momentum of recent high-level engagements with health agencies from around the wo
Vulnerabilities or disruptions to the global medicine supply chain (including drug shortages) con
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for th
